Featured News

 

Latest News

Enteris And Sanofi Combine To Treat Diabetes
Enteris And Sanofi Combine To Treat Diabetes
News   Jan 24, 2017

Enteris' Peptelligenceā„¢ drug delivery platform is to be used in a feasibility study by Sanofi to deliver their Type 2 Diabetes treatment.

READ MORE

Call For Entries For Eppendorf & Science Neurobiology Prize 2017
Call For Entries For Eppendorf & Science Neurobiology Prize 2017
News   Jan 24, 2017

Eppendorf and the journal Science are now accepting applications for their 2017 Neurobiology Prize, worth US$25k to young scientists making outstanding contributions in neurobiological research.

READ MORE

Cypralis Granted New Innovate UK Award
Cypralis Granted New Innovate UK Award
News   Jan 23, 2017

Cypralis have been granted an Innovate UK early stage award to develop cyclophilin D inhibitors.

READ MORE

"Collateral Lethality" Offers A new Therapeutic Approach
"Collateral Lethality" Offers A new Therapeutic Approach
News   Jan 20, 2017

Cancerous cells often delete genes that suppress tumor formation, often these genes deletions extend into neighboring genes, this is known as "collateral lethality".

READ MORE

Making Strides in Sickle Cell Disease Research
Making Strides in Sickle Cell Disease Research
News   Jan 20, 2017

The world's largest sickle stem cell disease library will contain a diverse range of samples that can be used to study the disease and develop therapeutics.

READ MORE

RNA Hitches A Ride On Ultrasound Waves
RNA Hitches A Ride On Ultrasound Waves
News   Jan 20, 2017

Technique enables rapid delivery of RNA to treat colon inflammation.

READ MORE

Immunoprofiler Iniative Launched By UCSF And Pharma
Immunoprofiler Iniative Launched By UCSF And Pharma
News   Jan 20, 2017

University of California San Francisco will partner with AbbVie, Amgen and Bristol Myers Squibb to analyse at least 500 tumour samples for immunologically relevant characteristics.

READ MORE

Investment boost for OCTIMET Oncology
Investment boost for OCTIMET Oncology
News   Jan 19, 2017

OCTIMET Oncology NV secures over EUR 11 million to develop its highly selective MET kinase inhibitors

READ MORE

New Method That Should Enhance the Discovery of New Drugs and the Study of Proteins
New Method That Should Enhance the Discovery of New Drugs and the Study of Proteins
News   Jan 19, 2017

A team of scientists at The Scripps Research Institute have developed a new method that enhances the discovery of new drugs and the study of proteins. The new method enables researchers to quickly find small molecules that bind to hundreds of thousands of proteins in their native cellular environment.

READ MORE

Pall ForteBio Acquires SensiQ's Pioneer SPR Product line
Pall ForteBio Acquires SensiQ's Pioneer SPR Product line
News   Jan 18, 2017

Pall ForteBio will acquire the assets related to SensiQ's Pioneer product line.

READ MORE